RAPT Therapeutics
RAPT58.0200.00% ( 0.000 )
Q3 FY2025 Earnings
Financial report interval: 2025.06.30 - 2025.09.30
Overview: RAPT Therapeutics(RAPT) the EBIT is -19.37 M (+2.11%);the EPS is -0.652 (+82.8%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.02B2.11%
----
----
EPS
-0.65282.80%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf